Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Aznar

Showing results (141-150 of 432) with videos related to

Pageof 44
Sort By:
Sangre|January 1, 1985
[Evaluation of serum ferritin in the A2 and F thalassemic syndromes]Y Mira, R Llopis, P Cubillo, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|January 15, 1999
[Characterization of the rpoB gene mutations in clinical isolates of rifampicin-resistant Mycobacterium tuberculosis]N González, M J Torres, J C Palomares, et al.
Thrombosis Research|November 1, 1985
Reduced fibrinolytic activity in coronary heart disease in basal conditions and after exerciseA Estellés, G Tormo, J Aznar, et al.
Thrombosis Research|May 1, 1992
Hemorheological alterations in mild essential hypertensionA Vayá, M Martínez, J Garcia, et al.
Journal of Clinical Microbiology|September 2, 2000
Use of real-time PCR and fluorimetry for rapid detection of rifampin and isoniazid resistance-associated mutations in Mycobacterium tuberculosisM J Torres, A Criado, J C Palomares, et al.
Thrombosis Research|March 1, 1987
Fibrinogen Barcelona I. Congenital dysfibrinogenemia characterized by defective release of fibrinopeptide A and fibrinogen degradation productsV Vila, E Regañón, J Aznar, et al.
Thrombosis Research|September 1, 1982
Elevated lipid peroxide levels in platelets of chronic ischemic heart disease patientsJ Valles, J Aznar, M T Santos, et al.
Thrombosis Research|May 1, 1980
Abnormal platelet lipid pattern in chronic heart disease patientsJ Aznar, J Valles, M T Santos, et al.
Thrombosis Research|August 15, 1986
The effect of EDTA on the production of prostacyclin by rat aortaJ Vallés, V Martínez-Sales, J Aznar, et al.
Thrombosis Research|June 1, 1992
Euglobulin clot lysis induced by tissue-type plasminogen activator is reduced in subjects with increased levels of lipoprotein (a)J Aznar, A Estellés, M Bretó, et al.
Pageof 44

Showing results (141-150 of 432) with videos related to

Sort By:
Pageof 44
Sangre|January 1, 1985
[Evaluation of serum ferritin in the A2 and F thalassemic syndromes]Y Mira, R Llopis, P Cubillo, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|January 15, 1999
[Characterization of the rpoB gene mutations in clinical isolates of rifampicin-resistant Mycobacterium tuberculosis]N González, M J Torres, J C Palomares, et al.
Thrombosis Research|November 1, 1985
Reduced fibrinolytic activity in coronary heart disease in basal conditions and after exerciseA Estellés, G Tormo, J Aznar, et al.
Thrombosis Research|May 1, 1992
Hemorheological alterations in mild essential hypertensionA Vayá, M Martínez, J Garcia, et al.
Journal of Clinical Microbiology|September 2, 2000
Use of real-time PCR and fluorimetry for rapid detection of rifampin and isoniazid resistance-associated mutations in Mycobacterium tuberculosisM J Torres, A Criado, J C Palomares, et al.
Thrombosis Research|March 1, 1987
Fibrinogen Barcelona I. Congenital dysfibrinogenemia characterized by defective release of fibrinopeptide A and fibrinogen degradation productsV Vila, E Regañón, J Aznar, et al.
Thrombosis Research|September 1, 1982
Elevated lipid peroxide levels in platelets of chronic ischemic heart disease patientsJ Valles, J Aznar, M T Santos, et al.
Thrombosis Research|May 1, 1980
Abnormal platelet lipid pattern in chronic heart disease patientsJ Aznar, J Valles, M T Santos, et al.
Thrombosis Research|August 15, 1986
The effect of EDTA on the production of prostacyclin by rat aortaJ Vallés, V Martínez-Sales, J Aznar, et al.
Thrombosis Research|June 1, 1992
Euglobulin clot lysis induced by tissue-type plasminogen activator is reduced in subjects with increased levels of lipoprotein (a)J Aznar, A Estellés, M Bretó, et al.
Pageof 44